New hope for lung cancer patients: experimental drug ZG006 takes on chemo in phase 3 trial
NCT ID NCT07189455
First seen Oct 31, 2025 · Last updated May 10, 2026 · Updated 22 times
Summary
This study tests whether the experimental drug ZG006 can help people with relapsed small cell lung cancer live longer compared to standard chemotherapy. About 420 adults aged 18 to 75 who are in fairly good health will be randomly assigned to receive either ZG006 or a chemotherapy chosen by their doctor. The main goal is to see if ZG006 improves overall survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Chest Hospital
RECRUITINGShanghai, Shanghai Municipality, 200030, China
Conditions
Explore the condition pages connected to this study.